Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Hardy Diagnostics recalls HardyCHROM CRE

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.
Products
  • HardyCHROM CRE
Where it was sold

US domestic distribution to the following states: AZ, CA, CO, FL, GA, IL, MD, ME, MI, MN, MO, NC, NE, NV, NY, PA, PR, TX, UT, VA, WI and WV.

States: Arizona, California, Colorado, Florida, Georgia, Illinois, Maryland, Maine, Michigan, Minnesota, Missouri, North Carolina, Nebraska, Nevada, New York, Pennsylvania, Puerto Rico, Texas, Utah, Virginia, Wisconsin, West Virginia

Units affected
4300 ea
About this recall
HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323